EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States

Joseph E Biskupiak, Mafalda Ramos, Carol J Levy, Greg Forlenza, Colin Hopley, Jennifer Boyd, Dan Swift, Mark Lamotte, Diana I Brixner

Journal of Managed Care & Specialty Pharmacy · 2023

DOI: 10.18553/jmcp.2023.22331 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Managed Care & Specialty Pharmacy, 2023. Verfasst von Joseph E Biskupiak und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacotherapy, University of Utah, Salt Lake City. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Hypoglycemia. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1HypoglycemiaMaleAdultChildHumansUnited StatesCost-Benefit AnalysisStandard of CareInsulinQuality-Adjusted Life Years

Substanzen

Insulin

Autor:innen und Institutionen

  • Department of Pharmacotherapy, University of Utah, Salt Lake City.
  • Global HEOR, IQVIA, Porto Salvo, Portugal.
  • Ichan School of Medicine at Mount Sinai, New York City, NY.
  • Children's Hospital, University of Colorado Denver, Aurora.
  • Insulet, Acton, MA.
  • Global HEOR, IQVIA, Zaventem, Belgium.

Zitieren

APA

Biskupiak, J. E., Ramos, M., Levy, C. J., Forlenza, G., Hopley, C., Boyd, J., Swift, D., Lamotte, M., & Brixner, D. I. (2023). Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. Journal of Managed Care & Specialty Pharmacy. https://doi.org/10.18553/jmcp.2023.22331

Vancouver

Biskupiak JE, Ramos M, Levy CJ, Forlenza G, Hopley C, Boyd J, et al. Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States. Journal of Managed Care & Specialty Pharmacy. 2023. doi:10.18553/jmcp.2023.22331

BibTeX
@article{Biskupiak2023,
  author = {Biskupiak, Joseph E and Ramos, Mafalda and Levy, Carol J and Forlenza, Greg and Hopley, Colin and Boyd, Jennifer and Swift, Dan and Lamotte, Mark and Brixner, Diana I},
  title = {Cost-effectiveness of the tubeless automated insulin delivery system vs standard of care in the management of type 1 diabetes in the United States},
  journal = {Journal of Managed Care & Specialty Pharmacy},
  year = {2023},
  doi = {10.18553/jmcp.2023.22331}
}
Kostenlos starten →